Trending...
- Healthcare Leaders Publish New Integrated Behavioral Healthcare Guide, Led by Doctors of Behavioral Health
- This Weekend Causeway Cove Country BBQ & Music Festival Returns for Fourth Year, Celebrating America's 250th Anniversary on the Water
- Connecta Satellite Solutions Ready to Support Emergency Communications Following the Venezuela Earthquake
Contact: Ryan Jarvi 517-599-2746Agency: Attorney General
November 17, 2020
LANSING — Michigan Attorney General Dana Nessel joined a coalition of 22 attorneys general in a letter to the U.S. Department of Health & Human Services (HHS) and its National Institutes of Health (NIH) urging them to reject recent recommendations made by the Trump administration's NIH Human Fetal Tissue Ethics Advisory Board (Board).
The Board's recommendation would withhold federal funding for fetal tissue research grant proposals, putting limits on research into possible treatments and therapies for various health conditions, including COVID-19. The recommendation comes after a two-year campaign by the Trump administration to block federally funded research using fetal tissue as well as an executive order to ban the research.
"While leading scientists are encouraging the use of fetal tissue research to develop treatments for the COVID-19 pandemic, the Trump administration is attempting to withhold critical funding for this important work," Nessel said. "Our country has been hard hit by this pandemic – this recommendation by the Board would effectively hinder advances in finding a treatment for this devastating virus. President Trump himself was treated for COVID with Remdesivir, a drug developed through fetal tissue research – why shouldn't every American have that opportunity?"
More on Michimich.com
Fetal tissue has been an essential part of scientific and medical advances that have saved millions of lives in the United States and across the globe. Fetal tissue was used in the research that led to the vaccines for poliovirus, rubella, measles and rabies. It remains a crucial part of vital biomedical research.
In its letter, the coalition argues the Board was not fairly balanced in terms of viewpoint, as two-thirds of its members are on record opposing abortion, fetal tissue or both. The Board's proceedings also lacked transparency. All of its meetings were in closed session except for one virtual meeting held for less than an hour. The attorneys general urge NIH Director Francis S. Collins and HHS Secretary Alex M. Azar II to use their authority to reject the Board's recommendations and maintain federal funding for research projects using fetal tissue that have already been recommended for funding.
In sending the letter, Attorney General Nessel joins the attorneys general of California, Colorado, Connecticut, Delaware, Hawaii, Illinois, Iowa, Maine, Maryland, Massachusetts, Minnesota, Nevada, New Jersey, New Mexico, New York, Oregon, Rhode Island, Vermont, Virginia, Wisconsin, and the District of Columbia.
A copy of the letter is available here.
November 17, 2020
LANSING — Michigan Attorney General Dana Nessel joined a coalition of 22 attorneys general in a letter to the U.S. Department of Health & Human Services (HHS) and its National Institutes of Health (NIH) urging them to reject recent recommendations made by the Trump administration's NIH Human Fetal Tissue Ethics Advisory Board (Board).
The Board's recommendation would withhold federal funding for fetal tissue research grant proposals, putting limits on research into possible treatments and therapies for various health conditions, including COVID-19. The recommendation comes after a two-year campaign by the Trump administration to block federally funded research using fetal tissue as well as an executive order to ban the research.
"While leading scientists are encouraging the use of fetal tissue research to develop treatments for the COVID-19 pandemic, the Trump administration is attempting to withhold critical funding for this important work," Nessel said. "Our country has been hard hit by this pandemic – this recommendation by the Board would effectively hinder advances in finding a treatment for this devastating virus. President Trump himself was treated for COVID with Remdesivir, a drug developed through fetal tissue research – why shouldn't every American have that opportunity?"
More on Michimich.com
- Roofman USA Expands Local Roofing Resources and Services Across Michigan Communities
- New MBA Research Examines What Drives Successful AI Adoption in Industry
- Sylvester Anthony III Introduces His Artist Journey with Debut Single "Cherish"
- Boston Industrial Solutions Introduces High-Performance Primer for Bonding Liquid Silicone to Epoxy
- Healthcare Leaders Publish New Integrated Behavioral Healthcare Guide, Led by Doctors of Behavioral Health
Fetal tissue has been an essential part of scientific and medical advances that have saved millions of lives in the United States and across the globe. Fetal tissue was used in the research that led to the vaccines for poliovirus, rubella, measles and rabies. It remains a crucial part of vital biomedical research.
In its letter, the coalition argues the Board was not fairly balanced in terms of viewpoint, as two-thirds of its members are on record opposing abortion, fetal tissue or both. The Board's proceedings also lacked transparency. All of its meetings were in closed session except for one virtual meeting held for less than an hour. The attorneys general urge NIH Director Francis S. Collins and HHS Secretary Alex M. Azar II to use their authority to reject the Board's recommendations and maintain federal funding for research projects using fetal tissue that have already been recommended for funding.
In sending the letter, Attorney General Nessel joins the attorneys general of California, Colorado, Connecticut, Delaware, Hawaii, Illinois, Iowa, Maine, Maryland, Massachusetts, Minnesota, Nevada, New Jersey, New Mexico, New York, Oregon, Rhode Island, Vermont, Virginia, Wisconsin, and the District of Columbia.
A copy of the letter is available here.
0 Comments
Latest on Michimich.com
- $20 Million Revenue Target, Accelerating Growth, 7% Of Outstanding Shares Retired, Clear Path Toward Profitability: VSee Health, Inc N A S D A Q: VSEE
- HomeCentris Home Health Achieves 5-Star CMS Rating
- Adsoptia Launches AI-Powered Optimization Platform for a New Era of Autonomous Marketing Decisions
- Jeffrey Animal Hospital of Michigan Acquired by Associated Veterinary Partners of New Jersey
- Rev. Wendell Anthony Endorses Korey Hall for Michigan State Senate District 3
- Heritage at Manalapan Announces New Incentive: Included Finished Basement on Select Homesites
- Leicester UK Manufacturer Tabletop Tyrant Secures Flawless 100% Customer Satisfaction Rating Across 5,800+ Orders
- The Calida Group Announces Promotion of Joshua Nelson to President, Advancing Next Phase of National Growth
- Cango Mobility x Hikvision Announce Strategic Partnership
- HomeCentris Healthcare Signs Definitive Agreement to Acquire S&K Holdings, Expanding Mid Atlantic Platform
- Nayarit Strengthens Its Position as a Global Surf Destination; Sayulita to Become Mexico's First Official Surf City
- Century Fasteners de Mexico Exhibiting at 2026 Farnborough International Airshow
- George Martinez Completes Community Re-distribution Initiative, Returning $5,000 In Campaign Resources To Anchorage Nonprofits
- Mister Omaha Tries The Turf At Lone Star Park
- Andrew D. Levine Releases The Lily Network, an Indian Noir Mystery of Power, Paperwork & Murder
- The Mapping Software Behind America's Viral Maps Just Got Faster and Smarter
- Longevityresearch.ca publishes cross-disease causal analysis quantifying endpoint reduction across 27 diseases
- Joulescope JS320 Launches to Help Engineers Develop Battery-Powered Devices with Greater Confidence
- Ghanaian Afrobeat Artist Praise Kusi Announces Upcoming EP "After 21:00" Releasing July 3, 2026
- TURRENTINE: A Family Legacy United Through Music